Valuation: Sandoz Group AG

Market Cap 40.13B 35.77B 33.14B 30.13B 56.53B 3,805B 57.46B 397B 156B 1,988B 151B 147B 6,357B P/E 2026 *
35.3x
P/E 2027 * 25x
Enterprise Value 43.86B 39.1B 36.22B 32.93B 61.8B 4,159B 62.81B 434B 171B 2,174B 165B 161B 6,949B EV / Sales 2026 *
3.63x
EV / Sales 2027 * 3.4x
Free-Float
94.15%
Yield 2026 *
1.16%
Yield 2027 * 1.44%

Last Transcript: Sandoz Group AG

1 day-0.89%
1 week+6.90%
Current month+8.07%
1 month+9.84%
3 months+17.89%
6 months+15.05%
Current year+32.40%
1 week 71.18
Extreme 71.18
77.46
1 month 66.88
Extreme 66.88
77.46
Current year 56.94
Extreme 56.94
77.46
1 year 47.73
Extreme 47.73
77.46
3 years 23.42
Extreme 23.42
77.46
5 years 22.7
Extreme 22.7
77.46
10 years 22.7
Extreme 22.7
77.46
Manager TitleAgeSince
Chief Executive Officer 59 2018-12-31
Director of Finance/CFO 58 2024-06-30
Chief Tech/Sci/R&D Officer 59 2025-05-31
Director TitleAgeSince
Director/Board Member 63 2023-07-31
Chairman 66 2023-02-28
Director/Board Member 61 2023-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/27/26 Sell -7,030 0.0016%
3/3/26 Sell 91 0.0000%
12/8/25 Sell 2,000 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%+6.90%+56.45%+180.46% 40.13B
-1.33%+4.88%+54.50%+109.94% 1,106B
-0.69%-3.77%+31.35%+66.62% 612B
-0.96%+0.55%+23.13%+94.26% 500B
+1.25%+7.12%+37.10%+61.26% 367B
-1.59%-1.25%+69.39%+43.02% 354B
+0.55%+4.98%+20.26%+47.69% 286B
+0.26%+4.62%-0.94%+19.33% 256B
-1.75%+1.76%+42.21%+51.44% 230B
-2.00%+1.75%+24.64%+95.14% 190B
Average -0.72%+2.70%+35.81%+76.91% 394.03B
Weighted average by Cap. -0.78%+2.36%+38.42%+76.86%

Financials

2026 *2027 *
Net sales 12.1B 10.78B 9.99B 9.08B 17.04B 1,147B 17.32B 120B 47.11B 599B 45.39B 44.44B 1,916B 12.75B 11.36B 10.52B 9.57B 17.96B 1,208B 18.25B 126B 49.64B 632B 47.82B 46.82B 2,019B
Net income 1.13B 1.01B 931M 847M 1.59B 107B 1.62B 11.17B 4.39B 55.89B 4.23B 4.14B 179B 1.66B 1.48B 1.37B 1.24B 2.34B 157B 2.37B 16.42B 6.46B 82.16B 6.22B 6.09B 263B
Net Debt 3.74B 3.33B 3.09B 2.81B 5.26B 354B 5.35B 37B 14.55B 185B 14.02B 13.72B 592B 3.26B 2.91B 2.7B 2.45B 4.6B 309B 4.67B 32.33B 12.71B 162B 12.25B 11.99B 517B
Projected Income Statement - Annual - Sandoz Group AG
Logo Sandoz Group AG
Sandoz Group AG specializes in the design, manufacturing and marketing of generic drugs and biosimilars. Net sales break down by family of products as follows: - generics (70.3%); - biosimilars (29.7%). Net sales are distributed geographically as follows: Switzerland (4.5%), Germany (12.8%), Europe (36.2%), the United States (16.5%), North America (5.5%) and other (24.5%).
Employees
20,000
Date Price Change Volume
26-10-20 CHF 76.02 -0.73% 93,519
26-10-19 CHF 76.58 -0.78% 1,228,199
26-10-16 CHF 77.18 +2.55% 1,177,371
26-10-15 CHF 75.26 +1.95% 1,217,432
26-10-14 CHF 73.82 +3.04% 915,336
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sandoz Group AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
92.74USD
Average target price
94.12USD
Spread / Average Target
+1.49%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sandoz Group AG